TL;DR
The COVID-19 pandemic's nonpharmaceutical interventions (NPIs) significantly altered the epidemiology and clinical presentation of Respiratory Syncytial Virus (RSV) infections in hospitalized children in Suzhou, China. While RSV activity initially declined, it later surged atypically in the summer, with infections becoming milder and more prevalent in older children, highlighting the need for adaptive healthcare planning.
What Problem Does This Paper Address?
Respiratory Syncytial Virus (RSV) is a major cause of acute lower respiratory infections (ALRIs) in young children, leading to millions of hospitalizations and deaths globally each year. The COVID-19 pandemic, with its widespread implementation of nonpharmaceutical interventions (NPIs) like social distancing, mask-wearing, and lockdowns, drastically changed human behavior and interaction patterns. These NPIs were primarily aimed at curbing SARS-CoV-2 transmission, but it was hypothesized that they would also impact the circulation of other respiratory pathogens, including RSV, which shares similar transmission routes. While some studies globally have noted changes in RSV patterns, there was a need for specific, localized data from regions like eastern China to understand how these pandemic-era public health measures affected RSV epidemiology and the severity of illness in hospitalized children, informing future healthcare strategies.
Methods
This study employed a retrospective design, analyzing data from hospitalized children under 18 years old diagnosed with ALRIs at the Soochow University Affiliated Children's Hospital in Suzhou, China. The data spanned from January 2018 to July 2022, allowing for a comparison of RSV infection patterns before and during the COVID-19 pandemic.
Key data collection methods included:
- Face-to-face questionnaire surveys: Gathered information from investigators.
- Medical record abstraction: Extracted patient demographics, underlying conditions, clinical manifestations, laboratory findings, and treatment details.
- Hospital information system queries: Accessed patient data.
Nasopharyngeal secretions were collected for pathogen detection using direct immunofluorescence assay (DFA) and real-time polymerase chain reaction (RT-PCR). Bacterial coinfections were assessed via sputum culture. Statistical analysis involved chi-squared tests, Fisher's exact tests, and Mann-Whitney-Wilcoxon tests to compare categorical and continuous variables, respectively. Multivariable logistic regression models were used to identify factors associated with prolonged hospital stays.
Datasets
The study utilized retrospective data from the Soochow University Affiliated Children's Hospital (SCH) in Suzhou, China. The dataset comprised records of hospitalized children with ALRIs from January 2018 to July 2022, encompassing a total of 9016 patients. This dataset allowed for a direct comparison of RSV infection trends and clinical characteristics across the pre-pandemic period (2018-2019) and the pandemic period (2020-2022). No new benchmarks were introduced; the study focused on analyzing existing clinical and epidemiological data.
Key Insights and Ideas
- NPIs as a Double-Edged Sword for RSV: The strict NPIs implemented for COVID-19 initially suppressed RSV activity, but the subsequent relaxation, coupled with potential "immunity debt" in the population, led to an unexpected and intense surge of RSV in the summer of 2021. This highlights the complex and sometimes delayed impact of public health interventions on endemic respiratory viruses.
- Shifting Age Demographics: The pandemic appears to have shifted the age distribution of RSV infections. While younger infants (<6 months) traditionally bear the brunt of RSV, the pandemic saw a relative increase in infections among older children (24-59 months and ≥60 months). This could be due to a lack of prior exposure during lockdown periods.
- Milder Clinical Presentations: A significant finding was that RSV infections during the pandemic were generally milder. This was evidenced by a decreased need for oxygen therapy, fewer cases of polypnea and wheeze, and a reduced proportion of patients requiring extended hospital stays (≥11 days).
- Bacterial Coinfections Decline: The study noted a decrease in bacterial coinfections among RSV-positive children during the pandemic. This, along with the milder clinical course, might be linked to the overall reduction in pathogen exposure due to NPIs.
Key Results
- RSV Positive Rates: The overall RSV positive rate was 13.8%. While 2020 showed no significant difference compared to the prepandemic period, 2021 and 2022 saw significant increases in RSV positive rates (20.8% and 18.9% respectively, p<0.001).
- Seasonal Shift: Pre-pandemic RSV peaked in winter months (October-March). During the pandemic, RSV rates declined in late 2020 but surged atypically in the summer of 2021, with higher intensity and longer duration than previous years.
- Age Distribution Changes: The proportion of RSV-positive children aged <6 months decreased during the pandemic, while the proportion of older children (24-59 months and ≥60 months) increased significantly.
- Clinical Severity: Compared to the prepandemic period, RSV-positive children during the pandemic had a lower proportion requiring hospital stays ≥11 days (6.7% vs. 10.3%, p<0.05), less need for oxygen therapy (6.9% vs. 13.7%, p<0.001), and fewer cases of polypnea (9.7% vs. 12.2%, p<0.05) and wheeze (42.9% vs. 50.1%, p<0.001).
- Laboratory Findings: A significant increase in low WBC counts (<5 *10^9/L) was observed during the pandemic (12.1% vs. 6.4%, p<0.001). Bacterial coinfections decreased significantly (19.1% vs. 30.2%, p<0.001).
Limitations and Future Work
The authors acknowledge several limitations:
- Healthcare-Seeking Behavior: The pandemic may have altered how parents sought medical care for their children, potentially influencing patient numbers and the severity of cases presenting at the hospital.
- NPI Compliance: The study did not assess the compliance levels with measures like hand hygiene and social distancing.
- DFA Test Accuracy: The use of DFA for RSV detection might have led to a slight underestimation of infection rates.
- Single-Center Study: The research was conducted at a single tertiary children's hospital in Suzhou, limiting generalizability to other regions.
Future work should focus on:
- Ongoing Monitoring: Continuous surveillance of RSV is crucial to understand evolving epidemiology and inform future healthcare system planning.
- Regional Comparisons: Further investigations across different regions are needed to provide a broader understanding of RSV patterns.
- Understanding Milder Illness: Further research is required to fully elucidate the mechanisms behind the observed milder clinical presentations during the pandemic, especially considering the potential for "immunity debt."
Summary updated